NATICK, Mass. (AUGUST 19, 2021) – AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced today that scientific co-founder Moonsoo Jin will present twice at Hanson Wade’s 6th CAR-TCR Summit being held virtually August 30 – September 2. Dr. Jin’s first presentation “Developing Manufacturing and Quality Control Platforms for Cell Immunotherapy” will occur as part of the CAR-TCR 101 Deep Dive Day Bootcamp at 1:30 pm EST on August 30. In this talk, he will explore strategies to optimize CMC for high quality cell production, summarize key quality … Continue reading AffyImmune Therapeutics to Present Initial Clinical Results at Upcoming CAR-TCR Summit